China's capital Beijing issued its second smog red alert of the month on Friday, triggering vehicle restrictions and forcing schools to close.» Read More
It was a complicated case, in part because the reform legislation itself was seriously flawed. The law’s drafters could have proposed a simpler and more efficient system, the New York Times reports.
Expecting Aetna and UnitedHealth to beat Wall Street estimates as health insurers kick off fourth-quarter earnings, senior analyst Peter Costa of Wells Fargo says these companies will continue their winning streak in 2012, due to rising costs, lower unemployment and even health-care reform.
Is legislated healthcare reform here to stay? As we watch the presidential race heat up – and look to a Supreme Court ruling this summer — no one knows for sure. Regardless, we as a nation need to realize that traditional thinking around healthcare is forever changed.
What if doctor's offices were like gym memberships? Pay a monthly fee and come as often as you like: no insurance, no deductible, no paperwork, no bill. It's called direct primary health care and may be available in your state.
While some people are frustrated about the long wait times for doctors appointments, some believe doctors are doing their jobs.
There's growing debate over whether America can afford Medicare as it is currently constructed and the costs sustainable.
Critics of the Affordable Care Act say they are not seeing any change in costs and are worried that government-run health care will increase taxes and allow insurance companies to operate without rules.
Many consumers assume that their health insurer, hospital, or state medical licensing agencies have vetted physicians who are open for business, but oversight is more lax than you might think.
What used to be mostly a matter of phony billing has spread to questionable medical procedures and identity theft, costing patients and insurers more than ever.
Though the U.S. had made much progress taking medical record keeping into the digital age, there's still some doubt that the government will reach its target by the prescribed deadline.
The reasons Americans pay more than other industrialized countries for similar health care come down to how the system is run, starting with the bottom line.
Like many things in America these days, health care has been politicized. While the policy debate may strike many in Washington as all-important, for the majority of average Americans health care is primarily a matter of goods and services
With so many Americans working as consultants or freelancers because of the bad economy, more people are paying for their own coverage. Here's a guide to finding a provider.
The Centers for Disease Control considers obesity in America an epidemic; more than one out of three adults and 17 percent of all children are technically overweight to the point of obesity.
Spending a month in China earlier this year left me with a clear picture of a nation of rapid change, vast scale, and stark contrasts. All of these factors create opportunities – and challenges – for American businesses in China, and particularly for those of us in health care.
Personalized medicine has finally arrived and is poised to deliver significant health improvement and healthcare cost savings.
The government is making an increasing number of expensive life-saving or life extending drugs and devices available to more people, but is that the right thing to do and can we afford it, anyway?
Health care is an emotional subject for many Americans — and often one of extremes. Yet, as we obssess about the system's structure and cost, we neglect our own health. Obesity and high blood pressure are more common, while exercise and diet are overlooked. Our special report, "Healthy Business", explores these issues.
More and more American women are seeking infertility treatment to increase their chances of having a child, but there's been no change in success rates and costs remain high, even with health insurance coverage.
Expected government cuts to Medicare and Medicaid, the uncertainty of health care reform and looming patent expirations are weighing heavily on the outlook of the biggest companies in the sector: large-cap pharmaceutical stocks.